Cyclacel Pharmaceuticals Statistics

Total Valuation

CYCC has a market cap or net worth of $996,973. The enterprise value is -$4.76 million.

Market Cap	996,973
Enterprise Value	-4.76M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

CYCC has 1.97 million shares outstanding. The number of shares has increased by 116.69% in one year.

Shares Outstanding	1.97M
Shares Change (YoY)	+116.69%
Shares Change (QoQ)	+39.10%
Owned by Insiders (%)	4.22%
Owned by Institutions (%)	14.95%
Float	1.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.15
Forward PS	n/a
PB Ratio	1.13
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.01.

Current Ratio	1.07
Quick Ratio	0.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-777.08

Financial Efficiency

Return on equity (ROE) is -570.69% and return on invested capital (ROIC) is -406.94%.

Return on Equity (ROE)	-570.69%
Return on Assets (ROA)	-102.53%
Return on Capital (ROIC)	-406.94%
Revenue Per Employee	$6,667
Profits Per Employee	-$1.47M
Employee Count	12
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-2.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.21% in the last 52 weeks. The beta is 0.56, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-94.21%
50-Day Moving Average	0.97
200-Day Moving Average	1.75
Relative Strength Index (RSI)	30.52
Average Volume (20 Days)	3,214,897

Short Selling Information

The latest short interest is 36,495, so 1.85% of the outstanding shares have been sold short.

Short Interest	36,495
Short Previous Month	47,934
Short % of Shares Out	1.85%
Short % of Float	2.08%
Short Ratio (days to cover)	1.10

Income Statement

In the last 12 months, CYCC had revenue of $80,000 and -$17.61 million in losses. Loss per share was -$9.75.

Revenue	80,000
Gross Profit	80,000
Operating Income	-20.20M
Pretax Income	-22.73M
Net Income	-17.61M
EBITDA	-20.19M
EBIT	-20.20M
Loss Per Share	-$9.75

Full Income Statement

Balance Sheet

The company has $6.00 million in cash and $5,000 in debt, giving a net cash position of $6.00 million or $3.04 per share.

Cash & Cash Equivalents	6.00M
Total Debt	5,000
Net Cash	6.00M
Net Cash Per Share	$3.04
Equity (Book Value)	999,000
Book Value Per Share	0.55
Working Capital	521,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.51M
Capital Expenditures	n/a
Free Cash Flow	-11.51M
FCF Per Share	-$5.83

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-25,255.00%
Pretax Margin	-25,452.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,167.93%

Dividends & Yields

CYCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.69%
Shareholder Yield	-116.69%
Earnings Yield	-1,422.56%
FCF Yield	-930.25%

Dividend Details

Analyst Forecast

The average price target for CYCC is $11.00, which is 2,078.22% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	2,078.22%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	229.49%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

CYCC has an Altman Z-Score of -81.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-81.97
Piotroski F-Score	1